51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Non-invasive imaging of transgene expression should soon play a critical role in gene and adoptive cellular gene therapy clinical trials. Positron emission tomography (PET) reporter genes (PRG)/probes (PRP) are currently the most advanced technologies available for imaging transgens in humans. PRGs can be used to image the location, magnitude, and time variation of the intensity of transgene expression throughout the whole body of a patient. This can eliminate the need for multiple biopsies, which are potentially dangerous and yet do not provide a complete picture of whole body transgene…mehr

Produktbeschreibung
Non-invasive imaging of transgene expression should
soon play a critical role in gene and adoptive
cellular gene therapy clinical trials. Positron
emission tomography (PET) reporter genes (PRG)/probes
(PRP) are currently the most advanced technologies
available for imaging transgens in humans. PRGs can
be used to image the location, magnitude, and time
variation of the intensity of transgene expression
throughout the whole body of a patient. This can
eliminate the need for multiple biopsies, which are
potentially dangerous and yet do not provide a
complete picture of whole body transgene expression
at multiple time points. This dissertation provides
details of several studies on direct and indirect
imaging of therapeutic transgenes using multiple
PRG/PRP systems in mice. Furthermore, it includes the
details of the first study on the pharmacokinetics,
dosimetry, and safety of an imaging reporter probe in
humans. Finally, a complete background on alternate
methods of imaging transgene expression has been
provided, concluding with a discussion of potential
future applications of imaging in gene therapy.
Autorenporträt
Dr. Yaghoubi is currently a research scientist at the department
of Radiology, Molecular Imaging Program at Stanford University.
He received his Bachelors in Science in Biomedical Engineering
from University of Southern California in 1996 and his Ph.D. in
Molecular and Medical Pharmacology from University of California,
Los Angeles in 2002.